Clinical Trial Update: pCHIP: Prostate Cancer Health Impact Program

View source ↗

Summary

The Prostate Cancer Health Impact Program (pCHIP) trial, sponsored by Weill Medical College of Cornell University, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Prostate Cancer | Status: TERMINATED